GILL ANN
CIK: 0002040268
Associated companies
Transaction History
| AX | ▲ Buy | Option Exercise | 1,643 | $152K | 9/15/2026 | View on chart |
| AX | ▼ Sell | Other | 884 | $82K | 9/15/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 601 | $50K | 3/20/2026 | View on chart |
| AX | ▼ Sell | Other | 323 | $27K | 3/20/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 773 | $65K | 3/15/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 675 | $57K | 3/15/2026 | View on chart |
| AX | ▼ Sell | Other | 458 | $39K | 3/15/2026 | View on chart |
| AX | ▼ Sell | Other | 399 | $34K | 3/15/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 1,000 | $79K | 11/15/2025 | View on chart |
| AX | ▼ Sell | Other | 538 | $43K | 11/15/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 906 | $80K | 9/23/2025 | View on chart |
| AX | ▼ Sell | Other | 487 | $43K | 9/23/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 727 | $66K | 9/15/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 527 | $48K | 9/15/2025 | View on chart |
| AX | ▼ Sell | Other | 283 | $26K | 9/15/2025 | View on chart |
| AX | ▼ Sell | Other | 391 | $35K | 9/15/2025 | View on chart |
| AX | ▼ Sell | Other | 383 | $26K | 3/24/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 712 | $48K | 3/24/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 674 | $43K | 3/15/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 773 | $49K | 3/15/2025 | View on chart |
| AX | ▼ Sell | Other | 457 | $29K | 3/15/2025 | View on chart |
| AX | ▼ Sell | Other | 398 | $25K | 3/15/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Axos Financial Faces Valuation Debate Amid Analyst Support
Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.
Axos Financial Faces Valuation Debate Amid Analyst Support. Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.